| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |